🦊/Investors

CARMA FUND

Venture capitaloperating company · company profile

Munich · Pre-Seed–Series A · 4 people tracked

Find your way into CARMA FUND

763 people in our graph share verified history with the CARMA FUND team — schools, employers, funds. One of them is your warm intro.

Peter Giordanounlockedknows Martin Müller · together at Berkeley SkyDeck Fund (overlapped)
knows the team · via Harvard Medical School
×2knows the team · via Heidelberg University
×6knows the team · via A.T. Kearney
×2knows the team · via Bayer
Fox Verdict
Sign up to see your fit

Investment thesis

CARMA FUND I invests early in Life Science and Healthcare companies and projects, aiming to help translate scientific innovation toward market entry. It targets therapeutics, diagnostics, medical devices, and digital health, as well as R&D tools and platform technologies. The fund positions itself as an active partner offering an extra-long term horizon, flexible investment modes, and close relationships with technology transfer offices and industry partners. It sees Europe as home to a strong therapeutics industry with experienced entrepreneurs and leading scientists, and welcomes funding applications from all European sources, addressing the specialist capital needs of biotech and healthcare innovators.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Munich, DE
Instruments
Equity
Founded
2022
AUM
$60M
Tracked investments
5

Team · 4 people

from public directories
Claus Schulte· Senior Investment Manager

What they invest in

from 3 of 5 portfolio companies

Digital Health ×3Biotech ×2Healthtech ×2Data & Infrastructure ×1Deep Tech ×1Medical Devices ×1Mental Health ×1

HQs:Germany×2

Investments · 5 tracked

founders shown can be your intro path
Elkedoniaelkedonia.comin

Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.

BiotechDigital HealthMental Health

Delphine Charvin(Founding Chief Executive Officer & Board Director)inMélanie Rouillier(VP, Chief Operations Officer & Co-Founder)inJocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)in

Co-investorsAngelini VenturesKurma Partners

O11 biomedical GmbHcarma-fund.com

Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMunich, DE

BoardChristian Leikert(Managing Partner)inDr. Martin Raditsch(Managing Partner)in

Thryvethryve.healthin

Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.

Data & InfrastructureDigital HealthHealthtechBerlin, DE

Friedrich Lämmel(CEO)inJohn Trimpop(CTO)Paul Burggraf(COO)in

Co-investorsKickstart InnovationAbstract VenturesDarling VenturesJoyance PartnersShanda GroupTMV+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Dimericon TherapeuticsSalvina Therapeutics

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has CARMA FUND made?
CARMA FUND has 5 tracked investments.
What stage does CARMA FUND invest at?
CARMA FUND invests at the Pre-Seed, Seed, Series A stages.
What sectors does CARMA FUND focus on?
CARMA FUND focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is CARMA FUND located?
CARMA FUND is headquartered in Munich, DE.
Who does CARMA FUND co-invest with?
CARMA FUND most often shares deals with BioMedPartners, Angelini Ventures, Kickstart Innovation, among 4 tracked co-investors.

Images

CARMA FUND photoCARMA FUND photo

Similar investors

Featured in lists